Practices now should have at least 1 person who understands analytics, as their prevalence and importance grows in the field, explained Nat Turner, co-founder and CEO of Flatiron Health.
Practices now should have at least 1 person who understands analytics, as their prevalence and importance grows in the field, explained Nat Turner, co-founder and CEO of Flatiron Health.
Transcript (slightly modified)
A few years ago, most physician practices were largely overwhelmed by the amount of data they were receiving. Are they getting any better at understanding these analytics?
I would say that’s still largely true, unfortunately, because the need for analytics has gotten bigger so not only are practices expanding their skills, but the world around them is getting more complicated. Oncology Care Model, I think, probably has a large part to do with that. Two-sided risk and other things that are looming are making them think about things ahead of time, which is nice.
The tools have gotten better, certainly Flatiron, but there are others that are providing good tools for analytics. Practices are getting smarter; I mean we’ve seen practices now hire CIOs or informatics people. Five years ago, when we started Flatiron, that was very rare, if ever did we see that. That’s really helping and I think that there is just a general acceptance that analytics is a thing now that you have to have. It’s not optional, you have to have someone in the practice at least who logs into analytics with whatever software they’re using. I think it’s getting better but it’s still pretty complicated.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More